Why Calumet Stock Is Up and Down Today
Key Points
Calumet reported strong earnings in Q3 but remains unprofitable over the last 12 months.
Management has decided to restate Q2 results.
- 10 stocks we like better than Calumet ›
Indianapolis-based oil products company Calumet (NASDAQ: CLMT) took investors on a roller-coaster ride after earnings Friday, rising as much as 13% only to fall 6% and then come (almost) back to breakeven again.
Calumet stock was still down 2.5% at 2:20 p.m. ET.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Image source: Getty Images.
Calumet Q3 earnings
Why all the commotion at Calumet? Obviously, it was because of the earnings released today.
Reporting Q3 2025 results, Calumet said sales declined 2%, to $1.1 billion, but earnings flipped from a year-ago Q3 loss to a big Q3 profit this time around. Q3 profits for 2025 were $3.61 per share, versus $1.18 in losses in Q3 2024, helped by "companywide cost reduction initiatives" that are on track to save $80 million in costs annually.
On the other hand, Calumet also announced today that, because of past "misclassification of certain amounts in the statement of cash flows between cash flows from operating activities and cash flows from financing activities," the company will need to restate its Q2 financials. Management noted the restatement will have no impact on the revenue or profits it reports and will in fact increase operating cash flow by about $80 million -- resulting in even better free cash flow (FCF) for the company.
Is Calumet stock a buy?
To me, this sounds like a positive development, potentially erasing Calumet's current $75 million FCF deficit and turning the company FCF-positive. Other investors may feel sufficiently uncertain that they will want to see the restated results, however, before deciding Calumet stock is safe to invest in.
If that's their decision, I can hardly fault it. Despite the positive Q3 earnings surprise, Calumet's still unprofitable over the last 12 months. It's hard to recommend buying the stock until they get that fixed.
Should you invest $1,000 in Calumet right now?
Before you buy stock in Calumet, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Calumet wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $591,613!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,152,905!*
Now, it’s worth noting Stock Advisor’s total average return is 1,034% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of November 3, 2025
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Recommended Articles
